{
    "nctId": "NCT02510430",
    "briefTitle": "The Plan and Stand Study: Reducing Sitting Time in Breast Cancer Survivors",
    "officialTitle": "Randomized Controlled Trial of Sitting Time Interventions in Breast Cancer Survivors",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Neoplasms",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "SUPPORTIVE_CARE",
    "enrollmentCount": 59,
    "primaryOutcomeMeasure": "Feasibility as measured by recruitment and retention rates",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. diagnosed with Stage 0-III breast cancer. Bilateral or multiple primary breast cancers are permitted.\n2. Completed primary treatment defined as definitive surgery, (neo)adjuvant chemotherapy and/or (neo)adjuvant radiation. Participants still receiving adjuvant endocrine or HER2 targeted therapies are eligible.\n3. Report sitting for \u22658 accumulated waking hours on a typical day,\n4. Willing and able to attend 3 study visits at the UW,\n5. Willing to attempt reduction of sitting time,\n6. Use the internet on a regular basis,\n7. Willing and able to complete study requirements, and\n8. Currently considered postmenopausal (no menstrual periods in past 12 months), even if pre-menopausal at diagnosis.\n\nExclusion Criteria:\n\n1. Evidence of recurrence or metastatic disease,\n2. Unable to move from sitting to standing without difficulty and to walk 1 block.",
    "sex": "FEMALE",
    "minimumAge": "N/A",
    "stdAges": "CHILD, ADULT, OLDER_ADULT"
}